ARPO Research and Charts

ARPO - Aerpio Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2021-11-14 (Delayed quote data 2024-12-26)

Last 3.10	Change ⇑ +0.10 (+3.33%)	Volume 287,392
	Open 2.95	High 3.10	Low 2.93

8EMA (Daily) 2.81	40EMA (Daily) 2.40	50EMA (Daily) 2.33	STO (Daily) 56.887	MACD Hist (Daily) 0.136
8EMA (Weekly) 2.634	40EMA (Weekly) 2.37	50EMA (Weekly) 2.62	STO (Weekly) 81.548	MACD Hist (Weekly) 0.331


Company Profile
Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product razuprotafib is a small molecule Tie2 activator being developed for the topical ocular treatment of primary open-angle glaucoma. Other products under the pipeline are ARP-1536 and AKB-4924.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.